Skip to main content
SpringerLink
Log in

Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The prevalence of serological parameters indicative of infection with hepatitis A, B and C was determined using sera collected from representative population samples in the former East German (new) federal states and the West German (old) federal states during the German National Health and Examination Survey in 1998. Sera were tested for antibodies to hepatitis A virus (HAV), to hepatitis B core antigen (HBc) and to hepatitis B surface antigen (HBsAg), hepatitis C Virus (HCV), as well as for the presence of HBsAg and HCV-RNA. The mean weighted prevalence of anti-HAV was 46.5% (95% CI: 45.3–47.7) and increased markedly with age. The mean weighted prevalence of past infection with hepatitis B was 7.7% (95% CI: 7.0–8.4) in the old federal states and 4.3% (95% CI: 3.2–5.3) in the new federal states, corresponding to an overall prevalence of 7.0% (95% CI: 6.4–7.6). The mean weighted prevalence of HBsAg carriage was 0.6% (95% CI: 0.4–0.8), while the prevalence of HCV antibodies was 0.4% (95% CI: 0.2–0.5).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Robinson WS. Hepatitis B virus and hepatitis D virus. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases, Philadelphia: Churchill Livingstone, 1995; 1406–1439.

    Google Scholar 

  2. Lemon SM, Brown EA. Hepatitis C virus. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases, Philadelphia: Churchill Livingstone, 1995; 1474–1486.

    Google Scholar 

  3. Robert Koch-Institut. Zur Situation bei wichtigen Infektionskrankheiten imJahr 1999. Teil 2: Virushepatitiden. Epidemiologisches Bulletin 2000; 28: 223–227.

    Google Scholar 

  4. Bellach B-M, Knopf H, Thefeld W. Der Bundes-Gesundheitssurvey 1997–1998. Gesundheitswesen 1998; 60(Suppl 2): S59–S68.

    Google Scholar 

  5. Thefeld W, Stolzenberg H, Bellach B-M. DeBundes-Gesundheitssurvey: Response, Zusammensetzung der Teilnehmer und Non-Responder-Analyse. Gesundheitswesen 1999; 61(Suppl 2): S57–S61.

    Google Scholar 

  6. Abb J. Praevalenz von Hepatitis-A-Virus-Antikoerpern bei Krankenhauspersonal (Prevalence of hepatitis A virus antibodies in hospital personnel). Gesundheitswesen 1994; 56(7): 377–379.

    Google Scholar 

  7. Hofmann F, Wehrle G, Berthold H, Koster D. Hepatitis A as an occupational hazard. Vaccine 1992; 10(Suppl 1): S82–S84.

    Google Scholar 

  8. Frö lich J, Zeller I. Hepatitis-A-Infektionsrisiko bei den Mitarbeitern einer grossen Kla¨ ranlagenbetreibergenbossenschaft (Risk of hepatitis A infection in persons working in a large-scale sewage plant co-operative). Arbeitsmedizin Sozialmedizin Praventivmedizin 1993; 28(11): 503–505.

    Google Scholar 

  9. Nothdurft HD, Loescher T. Folgen importierter Tropenkrankheiten in Deutschland. (Sequelae of imported tropical diseases in Germany). Versicherungsmedizin 1994; 46(4): 135–137.

    Google Scholar 

  10. Statistisches Bundesamt, (ed.) Statistisches Jahrbuch 1998, Wiesbaden: Metzler/Poeschel, 1998.

    Google Scholar 

  11. Statistisches Bundesamt, (ed.) Statistisches Jahrbuch 1993, Wiesbaden: Metzler/Poeschel, 1993.

    Google Scholar 

  12. Schenzle D, Dietz K, Froesner GG. Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys. AmJ Epidemiol 1979; 110(1): 70–76.

    Google Scholar 

  13. Studer S, Joller-Jemelka HI, Steffen R, Grob PJ. Prevalence of Hepatitis A antibodies in Swiss travellers. Eur J Epidemiol 1993; 9: 50–54.

    Google Scholar 

  14. Prodinger WM, Larcher C, Solder BM, Geissler D, Dierich MP. Hepatitis A in western Austria – the epidemiologic situation before the introduction of active immunisation. Infection 1994; 22: 53–55.

    Google Scholar 

  15. Beutels M, Van den Hoek JA, Vrancks R, Meheus A. The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterol Belgica 1998; 61: 4–7.

    Google Scholar 

  16. Thefeld W, Seher C, Dortschy R. Hepatitis-B-Durchseuchung in der deutschen Bevölkerung. Vergleich zwischen neuen und alten Bundesländern. Bundesgesundheitsbl 1994; 9: 374–377.

    Google Scholar 

  17. Resina RA, Zawati FZ, Grandal DC. Prevalencia de marcodores serologicos del virus de la hepatitis B en poblacion extrahospitalaria de la ciudad de Vigo. Atencion Primaria 1992; 10: 1028–1029.

    Google Scholar 

  18. Hart G. Factors associated with Hepatitis B infection. Int J STD AIDS 1993; 4(2): 102–106.

    Google Scholar 

  19. Kiehl W. ZumAblauf der HIV-Epidemie und zur AIDS-Prävention in der ehemaligen DDR. AIDS Nachrichten 1990; 5: 14–18.

    Google Scholar 

  20. Joller-Jemelka H, Wicki A, Grob P. Detection of HBs antigen in ‘anti-HBc alone’ positive sera. J Hepatol 1994; 21: 269–272.

    Google Scholar 

  21. Neifer S, Molz B, Sucker U, Kreuzpaintner E, Weinberger K, Jilg W. Hoher Prozentsatz isoliert anti-HBcpositiver Personen unter Strafgefangenen. Gesundheitswesen 1997; 59: 409–412.

    Google Scholar 

  22. Palitzsch KD, Hottentraeger B, Schlottmann K, et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 1999; 11(11): 1215–1220.

    Google Scholar 

  23. Christensen B, Boettiger M, Grillner L. The prevalence of hepatitis B in Sweden: A statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect 1997; 119(2): 221–225.

    Google Scholar 

  24. García-Fulgueiras A, Tormao MJ, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of Hepatitis B and C markers in the south-east of Spain: An unlinked community-based serosurvey of 2203 adults. Scand J Infect Dis 1996; 28(1): 17–20.

    Google Scholar 

  25. Stark K, Schreier E, Mueller R, Wirth D, Driesel G, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scandinavian J Infect Dis 1995; 27(4): 331–337.

    Google Scholar 

  26. Koerner K, Cardoso M, Dengler T, Kerowgan M, Kubanek B. Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang 1998; 74(4): 213–216.

    Google Scholar 

  27. Hillemanns P, Langenegger P, Langer BCA, Knitza R, Hasbargen U, Hepp H. Prävalenz und Verlauf der Hepatitis-C-Virusinfektion in der Schwangerschaft. Z Geburtsh Neonatol 1998; 202: 127–130.

    Google Scholar 

  28. Weber B, Rabenau H, Berger A, et al. Seroprevalence of HCV, HAV, HDV, HCMV and HIV in high risk groups /Frankfurt a.M. Germany. Zbl Bakt 1995; 282: 102–110.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Robert Koch-Institut, Berlin, Germany

    W. Thierfelder, W. Hellenbrand, E. Schreier & R. Dortschy

  2. Humboldt-Universität Berlin, Charité, Berlin, Germany

    H. Meisel

Authors
  1. W. Thierfelder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Hellenbrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Meisel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Schreier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Dortschy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thierfelder, W., Hellenbrand, W., Meisel, H. et al. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 17, 429–435 (2001). https://doi.org/10.1023/A:1013792013184

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013792013184

Search

Navigation